DRI Healthcare Trust (TSE:DHT.UN) Price Target Raised to C$23.00 at Canaccord Genuity Group

DRI Healthcare Trust (TSE:DHT.UN) had its target price lifted by stock analysts at Canaccord Genuity Group from C$22.25 to C$23.00 in a research note issued to investors on Tuesday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s price target would indicate a potential upside of 27.71% from the company’s previous close.

A number of other equities analysts also recently issued reports on the stock. Scotiabank raised their price objective on shares of DRI Healthcare Trust from C$25.00 to C$30.00 and gave the stock a “sector outperform” rating in a report on Tuesday, May 19th. Stifel Nicolaus increased their price target on shares of DRI Healthcare Trust from C$23.00 to C$24.00 and gave the stock a “buy” rating in a research report on Tuesday. Raymond James Financial lifted their price target on shares of DRI Healthcare Trust from C$22.50 to C$23.50 and gave the stock a “strong-buy” rating in a research note on Monday. Finally, National Bank Financial boosted their price objective on shares of DRI Healthcare Trust from C$22.50 to C$23.50 and gave the company an “outperform” rating in a research report on Tuesday, May 19th. One investment analyst has rated the stock with a Strong Buy rating and four have given a Buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of C$24.80.

DRI Healthcare Trust Stock Performance

Shares of TSE:DHT.UN traded down C$0.50 during midday trading on Tuesday, reaching C$18.01. 45,612 shares of the company’s stock traded hands, compared to its average volume of 59,601. The company has a market cap of C$990.84 million, a price-to-earnings ratio of -20.01 and a beta of 0.47. DRI Healthcare Trust has a one year low of C$13.24 and a one year high of C$19.04. The stock has a 50 day moving average of C$17.17 and a 200 day moving average of C$16.64.

DRI Healthcare Trust Company Profile

DRI Healthcare Trust is managed by DRI Capital Inc DRI a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable patent-protected cash flow streams derived from the sales of those important drugs while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products and proudly work with multiple repeat deal partners.DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21 2020 as amended.DRI Healthcare Trusts units are listed and trade on the Toronto Stock Exchange under DHT.UN in Canadian dollars and under DHT.U in U.S.